Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Biosensors, Microfluidics and Lab-on-a-Chip Technologies

Manabu Tokeshi's Biography



Manabu Tokeshi, Professor, Hokkaido University

Manabu Tokeshi is a Professor at the Division of Applied Chemistry at Hokkaido University. He is also a Visiting Professor at Innovative Research Center for Preventive Medical Engineering and Institute of Innovation for Future Society at Nagoya University. He received his PhD degree from Kyushu University in 1997. After a research fellow of the Japan Society of Promotion of Science at The University of Tokyo, he worked at Kanagawa Academy of Science and Technology as a research staff (1998-1999), a group subleader (1999-2003), and a group leader (2003-2004). He also worked at the Institute of Microchemistry Technology Co. Ltd. as President (2004-2005) and at Nagoya University as an Associate Professor (2005-2011). In 2011, he visited Karolinska Institutet as a Visiting Researcher and he joined the Hokkaido University as a Professor. His honors include the Outstanding Researcher Award on Chemistry and Micro-Nano Systems from the Society for Chemistry and Micro-Nano Systems (2007), the Pioneers in Miniaturisation Prize from the Lab on a Chip (The Royal Society of Chemistry)/Corning Inc. (2007), the Masao Horiba Award from HORIBA, Ltd. (2011), The Japan Society for Analytical Chemistry Award (2018) and Fellow of Royal Society of Chemistry (FRSC) (2019). His research interests are in the development of micro- and nano-systems for chemical, pharmaceutical and clinical applications.

Manabu Tokeshi Image

New Approaches for Medical Diagnosis and Therapy Using Microfluidic Devices

Thursday, 11 May 2017 at 10:15

Add to Calendar ▼2017-05-11 10:15:002017-05-11 11:15:00Europe/LondonNew Approaches for Medical Diagnosis and Therapy Using Microfluidic DevicesSELECTBIOenquiries@selectbiosciences.com

This presentation reports the development of a new platform of immunoassay device for detection of brain tumor. Using this devices, we succeeded in detection of grade II and III gliomas from patients within 15 min.


Add to Calendar ▼2017-05-10 00:00:002017-05-11 00:00:00Europe/LondonBiosensors, Microfluidics and Lab-on-a-Chip TechnologiesSELECTBIOenquiries@selectbiosciences.com